Back to search

Switzerland· 62329004

Livazo 2 mg, Filmtabletten

A pitavastatin product containing pitavastatinum, registered in Switzerland by RECORDATI AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C10AA08

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLivazo 2 mg, FilmtablettenATCC10AA08REGISTER NO.62329004PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pitavastatin is registered in 12 of 19 countries.

Countries holding a registration under ATC C10AA08 (pitavastatin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Pitavastatin · ATC C10AA08

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pitavastatin costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.43 in Spain to $3.35 in United States — a ×7.7 gap.

  • Switzerland: $1.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Pitavastatin · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • US United States$3.35 (acquisition cost)
  • CH Switzerland$1.57
  • ES Spain$0.43
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
pitavastatinum
Manufacturer
RECORDATI AG
Country
Switzerland (CH)
ATC code
C10AA08
ATC class
Pitavastatin
Defined daily dose
2 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680623290045
    90 Stk
    CHF 100.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

116 interactions on record for pitavastatin.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pitavastatin · interactions on record

116 records

  • 7 severe
  • 103 moderate
  • 2 minor

Most severe, free to view

  • ErythromycinJ01FA01severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • CiclosporinL04AD01severe

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pitavastatin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pitavastatin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Trolise
  • Bulgaria · Липоканте, Питавиа
  • Cyprus · Vaspit
  • Czechia · Pitilox
  • Germany · Livazo, Pitavastatin
  • Spain · Alipza, Lipix
  • France · Lippiza, Trolise
  • Greece · Fiarat, Livazo
  • Hungary · Pitilox
  • Ireland · Livazo
  • Italy · Livazo
  • Lithuania · Pitipix
  • Malta · Vaspit
  • Netherlands · Livazo
  • Norway · Livazo
  • Poland · Livazo, Pitamet
  • Portugal · Alipza, Livazo
  • Romania · Pitipix
  • Slovenia · Pitipix
  • Slovakia · Pitipix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d37f1a30-7e9a-45de-a23b-619a60e72298
GET /v1/drugs/d37f1a30-7e9a-45de-a23b-619a60e72298?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "pitavastatinum 2 mg",
  "valid_from": "2012-11-01",
  "limitations": "[{\"description\":\"Bei Erwachsenen ab 18 bis und mit 75 Jahren wird eine Behandlung mit Statinen vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie sowie bei Personen mit einem Risiko von über 1% nach AGLA-Risikokategorie. Eine entsprechend bis und mit 75 Jahren gestartete Statin-Therapie wird auch nach Vollendung des 75. Lebensjahres weiter vergütet.<br>\\nBei Personen über 75 Jahren wird eine neu beginnende Statin-Therapie nur vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie.<br>\\nLivazo wird zudem vergütet bei Jugendlichen und Kindern ab 6 Jahren mit primärer Hypercholesterinämie, einschliesslich heterozygoter familiärer Hypercholesterinämie, zusammen mit einer unterstützenden Diät, wenn Diät und andere nicht-pharmakologische Massnahmen (z.B. Bewegung und Gewichtsreduktion) keine ausreichende Wirkung erbringen.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-08-01\"}]",
  "galenic_form": "Filmtabl 2 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-11-01",
  "self_retention_pct": 10
}

See everything about pitavastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.